Literature DB >> 24255755

Factors affecting the time to recurrence after radical nephrectomy for localized renal cell carcinoma.

Hee-Seo Son1, Seung Hyun Jeon, Sung-Goo Chang.   

Abstract

PURPOSE: The objective of this study was to determine the factors affecting the time to recurrence after radical nephrectomy for localized renal cell carcinoma.
MATERIALS AND METHODS: We retrospectively evaluated 321 patients who received radical nephrectomies for localized renal cell carcinoma (pT1a-pT2b N0M0). Of 29 patients with disease recurrence, 9 had recurrence more than 5 years after radical nephrectomy. We evaluated the clinicopathological factors, with the use of a retrospective study design.
RESULTS: Tumor necrosis was statistically different between the late recurrence group and the recurrence free group (Fisher exact test, p=0.046). Hematuria at diagnosis (chi-square test, p=0.045) was statistically significant in early recurrence. In the univariate logistic regression analysis, tumor necrosis (odds ratio [OR], 4.629; 95% confidence interval [CI], 1.106 to 19.379; p=0.036) and pT stage>1 (OR, 7.232; 95% CI, 1.727 to 30.280; p=0.007) were risk factors of late recurrence. In the multivariable logistic regression analysis, pT stage>1 (OR, 7.143; 5% CI 1.706 to 29.912, p=0.007) was associated with late recurrence. Regarding early recurrence, initial symptoms at diagnosis and pathologic T stage>1 were statistically significant in both univariate and multivariable logistic regression analysis. In terms of recurrence site, patients with late recurrence tended to have unusual metastasis sites other than lung, liver or bone (chi-square test, p=0.012).
CONCLUSIONS: These data suggest that tumor necrosis may affect late disease recurrence. Patients with initial symptoms and hematuria at diagnosis are vulnerable to recurrence in a shorter period after nephrectomy. Patients with late recurrence showed a tendency to have unusual metastasis site other than lung, liver or bone.

Entities:  

Keywords:  Disease-free survival; Recurrence; Renal cell carcinoma

Year:  2013        PMID: 24255755      PMCID: PMC3830966          DOI: 10.4111/kju.2013.54.11.744

Source DB:  PubMed          Journal:  Korean J Urol        ISSN: 2005-6737


  22 in total

1.  Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: the D-SSIGN score.

Authors:  R Houston Thompson; Bradley C Leibovich; Christine M Lohse; John C Cheville; Horst Zincke; Michael L Blute; Igor Frank
Journal:  J Urol       Date:  2007-02       Impact factor: 7.450

2.  Late recurrence of renal cell carcinoma: retrospective and collaborative study of the Japanese Society of Renal Cancer.

Authors:  Noriomi Miyao; Seiji Naito; Seiichiro Ozono; Nobuo Shinohara; Naoya Masumori; Tatsuo Igarashi; Masahiro Nakao; Tomoyasu Tsushima; Yutaka Senga; Shigeo Horie; Hiro-omi Kanayama; Noriaki Tokuda; Mikio Kobayashi
Journal:  Urology       Date:  2010-10-23       Impact factor: 2.649

3.  Histologic tumor necrosis is an independent prognostic indicator for clear cell and papillary renal cell carcinoma.

Authors:  Martin Pichler; Georg C Hutterer; Thomas F Chromecki; Johanna Jesche; Karin Kampel-Kettner; Peter Rehak; Karl Pummer; Richard Zigeuner
Journal:  Am J Clin Pathol       Date:  2012-02       Impact factor: 2.493

4.  Predictive factors for late recurrence in patients with stage T1 clear cell renal cell carcinoma: a multiinstitutional study.

Authors:  Yun-Sok Ha; Yong Hyun Park; Seok Ho Kang; Sung-Hoo Hong; Tae-Kon Hwang; Seok-Soo Byun; Yong-June Kim
Journal:  Clin Genitourin Cancer       Date:  2012-09-25       Impact factor: 2.872

5.  Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma.

Authors:  Sang Eun Lee; Seok-Soo Byun; Jin Kyu Oh; Sang Chul Lee; In Ho Chang; Gheeyoung Choe; Sung Kyu Hong
Journal:  J Urol       Date:  2006-10       Impact factor: 7.450

Review 6.  Prognostic models and algorithms in renal cell carcinoma.

Authors:  Brian R Lane; Michael W Kattan
Journal:  Urol Clin North Am       Date:  2008-11       Impact factor: 2.241

7.  Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.

Authors:  Vitaly Margulis; Michelle McDonald; Pheroze Tamboli; David A Swanson; Christopher G Wood
Journal:  J Urol       Date:  2009-03-14       Impact factor: 7.450

8.  Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).

Authors:  Sabine Brookman-May; Matthias May; Shahrokh F Shariat; Evanguelos Xylinas; Christian Stief; Richard Zigeuner; Thomas Chromecki; Maximilian Burger; Wolf F Wieland; Luca Cindolo; Luigi Schips; Ottavio De Cobelli; Bernardo Rocco; Cosimo De Nunzio; Bogdan Feciche; Michael Truss; Christian Gilfrich; Sascha Pahernik; Markus Hohenfellner; Stefan Zastrow; Manfred P Wirth; Giacomo Novara; Marco Carini; Andrea Minervini; Claudio Simeone; Alessandro Antonelli; Vincenzo Mirone; Nicola Longo; Alchiede Simonato; Giorgio Carmignani; Vincenzo Ficarra
Journal:  Eur Urol       Date:  2012-06-22       Impact factor: 20.096

9.  Validation of a postoperative prognostic model consisting of tumor microvascular invasion, size, and grade to predict disease-free and cancer-specific survival of patients with surgically resected renal cell carcinoma.

Authors:  Matthias May; Sabine Brookman-Amissah; Friederike Kendel; Nina Knoll; Jan Roigas; Bernd Hoschke; Kurt Miller; Christian Gilfrich; Sandra Pflanz; Oliver Gralla
Journal:  Int J Urol       Date:  2009-05-13       Impact factor: 3.369

10.  Metastatic breast cancer shows different immunohistochemical phenotype according to metastatic site.

Authors:  Ja Seung Koo; Woohee Jung; Joon Jeong
Journal:  Tumori       Date:  2010 May-Jun
View more
  1 in total

1.  Isolated late intradural cauda equina metastasis of renal cell carcinoma.

Authors:  Sundus Ali; Adnan Qasim; Rahmatullah Salah; Muhammad Rizwan Sarwar; Muhammad Usman; Shahzad Shams
Journal:  Surg Neurol Int       Date:  2021-09-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.